Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target. (Q51038797)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target. |
scientific article published in April 2004 |
Statements
Perfusion of 99Tcm-labeled CD105 Mab into kidneys from patients with renal carcinoma suggests that CD105 is a promising vascular target. (English)
1 reference
Brendan Costello
1 reference
Chenggang Li
1 reference
Sarah Duff
1 reference
David Butterworth
1 reference
Ali Khan
1 reference
Michael Perkins
1 reference
Susan Owens
1 reference
Abdul Fattah Al-Mowallad
1 reference
Sarah O'Dwyer
1 reference
Shant Kumar
1 reference
1 April 2004
1 reference
109
1 reference
3
1 reference
436-441
1 reference
Identifiers
1 reference